India Pneumococcal Vaccine Market Report Outlook 2030 by TechSci Research

Market Outlook: India Pneumococcal Vaccine Market
The India pneumococcal vaccine market is projected to grow from USD 32.52 million in 2024 to USD 48.67 million by 2030, reflecting a CAGR of 6.91%. Growth is being driven by strong government initiatives, such as the inclusion of the Pneumococcal Conjugate Vaccine (PCV) in the Universal Immunization Programme (UIP), rising awareness about pneumonia-related mortality-especially in children-and enhanced local production by domestic manufacturers.

Support from international organizations like WHO, Gavi, and UNICEF also plays a vital role in expanding vaccine access, particularly in underserved regions. However, challenges remain, including low adult vaccination rates, limited awareness in high-risk populations, supply chain constraints, and vaccine hesitancy in rural areas. Despite these hurdles, continuous R&D, robust immunization programs, and improving healthcare infrastructure are expected to sustain momentum and expand vaccine coverage across India.

📘 Explore in-depth market data across 180+ pages: India Pneumococcal Vaccine Market Report- https://www.techsciresearch.com/report/india-pneumococcal-vaccine-market/27720.html

Key Market Drivers
1. Government-Led Immunization Initiatives
India's pneumococcal vaccine market is being fueled by strong policy support and public health programs. The UIP, now including PCV, has significantly expanded vaccine coverage in high-burden states like Uttar Pradesh, Bihar, and Maharashtra. Campaigns like SAANS have further strengthened outreach:
• Example: Under SAANS, nearly 2 million PCV doses were administered in Jharkhand between Nov 2024 and Feb 2025, helping reduce childhood pneumonia deaths.

2. Rising Pneumococcal Disease Burden
India accounts for 25% of the global childhood pneumonia burden, with 8 million severe cases annually, half requiring hospitalization. Awareness campaigns and community outreach are boosting vaccine demand across all demographics.

3. Domestic Manufacturing and Infrastructure Expansion
India's healthcare infrastructure and manufacturing capabilities are rapidly expanding:
• Example: Serum Institute of India and Bharat Biotech, supported by a $610 million government grant, have increased production of affordable vaccines like PNEUMOSIL, reducing import dependency and improving vaccine accessibility.

4. Demographic Trends
With India's elderly population projected to reach 347 million by 2050, the market for adult pneumococcal vaccines is set to grow. However, adult immunization rates remain low, presenting a key area for intervention.

5. International Collaboration
Global health bodies like Gavi, UNICEF, and WHO contribute significantly to vaccine rollout efforts, especially in hard-to-reach areas by funding, training, and improving distribution networks.

Market Trends
1. Persistent Government Engagement
India's pneumococcal vaccine market is strongly shaped by policy continuity. Large-scale programs like UIP and SAANS are achieving notable success in increasing vaccination rates in underserved regions.

2. Demand from Pediatric and Geriatric Segments
While childhood vaccination rates are high, demand is rising among the elderly due to growing awareness of pneumonia risks. Bridging the gap in adult coverage remains a priority.

3. Focus on Indigenous, Cost-Efficient Production
The rollout of affordable, domestically manufactured vaccines such as Pneumosil has improved supply stability and reduced costs, enhancing access in rural and low-income areas.

4. Strengthened Immunization Infrastructure
Routine integration of PCV into immunization schedules, along with growing hospital and clinic outreach, is improving nationwide coverage. Enhanced supply chain systems and digital health initiatives are further aiding distribution.

Market Segmentation
• By Vaccine Type:
o Pneumococcal Conjugate Vaccine (PCV)
o Pneumococcal Polysaccharide Vaccine (PPSV)
• By End Use:
o Public Sector
o Private Sector
• By Region:
o North India
o South India
o East India
o West India

Regional Insights: North India at the Forefront
North India leads the national market, thanks to:
• High population density
• Strong state-level UIP execution
• Concentration of healthcare institutions
• Higher incidence of respiratory infections

States like Uttar Pradesh, Delhi, Punjab, and Haryana have seen notable improvements in vaccine uptake, driven by both public-sector procurement and increased rural accessibility.

🎯 Get your free sample now: Download Sample Report - https://www.techsciresearch.com/sample-report.aspx?cid=27720

Linkedin - https://www.linkedin.com/pulse/india-pneumococcal-vaccine-market-growth-66dof/

Contact
US -
Techsci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +13322586602
Email: sales@techsciresearch.com
Web: https://www.techsciresearch.com/

TechSci Research is a research based management consulting firm providing market research and advisory solutions to its customers worldwide, spanning a range of industries.

TechSci Research's core values are value, integrity and insight. Led by a team of dynamic industry experts, TechSci Research provides its customers with high value market research and advisory services that helps them identify new market opportunities, growth engines and innovative ways to capture the market share. As a result, TechSci's client leads rather than follow market trends. Not bound by legacy, TechSci's cutting-edge research model leverages its decades of research knowledge and an increased use of technology as engines of innovation to deliver unique research value. Provided as an alternative to traditional market research, TechSci Research reports do not just deliver data and knowledge rather highlights the insights in a more usable and interactive format for its clients.

TechSci Research is committed to assisting customers worldwide with their unique market research needs by providing them with comprehensive, value-added solutions and professional market intelligence services. TechSci Research employs the industry's best-trained industry Analysts and Consultants, which advises and assists customers in meeting their full service market research and consulting requirements.

This release was published on openPR.